Global IoT Sensor Market will reach USD 27.38 by 2022 - Industry News Alert
Auris Medical Holding AG (EARS) and Verona Pharma plc (NASDAQ:VRNA) Contrasting side by side The Hi New UlmAuris Medical Holding AG (NASDAQ:EARS) and Verona Pharma plc (NASDAQ:VRNA) have been rivals
Contrasting of Aptose Biosciences Inc. (APTO) and Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) The Hi New UlmWe are comparing Aptose Biosciences Inc. (NASDAQ:APTO) and Navidea Biopharmaceutical
Asthma and Allergy Foundation of America Offers Free Online Course for Severe Asthma GlobeNewswireNew Program Aims to Improve Severe ASTHMA Care for Adults.
Ambient Benzene Exposure and Risk of Hematologic Malignancies Cancer Therapy AdvisorResearchers examined low-level estimates of ambient benzene to investigate whether it was associated with increased
Comparison of Surface Oncology Inc. (SURF) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) Th? M?n?t?rBoth Surface Oncology Inc. (NASDAQ:SURF) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) compete on a
Eisai and Empatica Enter an Agreement to Co-Promote the Embrace2 Device for People Living With Epilepsy in the US PRNewswireWOODCLIFF LAKE, N.J. and BOSTON, Feb. 19, 2019 /PRNewswire/ -- Eisai Inc.,
Avelumab Shows Stable Clinical Activity, Manageable Safety in Metastatic Urothelial Cancer Oncology Learning NetworkSan Francisco, California-Administering avelumab therapy in patients with metastati
Top News in Oncology February 19 2019 (1 of 1) MD LinxYale School of Medicine News | February 19, 2019. Many patients treated for metastatic melanoma develop resistance to an otherwise effective drug
Health Highlights: Feb. 18, 2019 | Health News U.S. News & World ReportImmunotherapies Prove Their Mettle Against Kidney Cancer Chronic Wasting Disease Found in Deer in 24 States.
Donald Paul Lombardi, MD Joins The Oncology Institute of Hope and Innovation PR WebCerritos (PRWEB) February 19, 2019 -- Dr. Lombardi is a board-certified oncologist that brings over 30 years of medi
Global Asthma and COPD Drugs Market 2018 : GlaxoSmithKline, Novartis, Merck, Abbott Laboratories, Boehringer Ingelheim, AstraZeneca, Roche Holding AG, Teva Pharmaceutical Industries, Vectura Group, Pf
FDA Grants Priority Review to Entrectinib for Two Treatment Indications Curetoday.comThe Food and Drug Administration (FDA) granted a priority review to entrectinib for the treatment of adult and ped
Gastric Acid Suppression & Oral Cancer Therapy Should Not Mix MedscapeGastric acid suppressants may reduce absorption of oral cancer drugs, as shown in a study with pazopanib for sarcoma in which the
Health Highlights: Feb. 18, 2019 HealthDayImmunotherapies Prove Their Mettle Against Kidney CancerChronic Wasting Disease Found in Deer in 24 States.
Rexahn Presents Updated Interim Data From Phase 2a Trial of RX-3117 in Advanced Bladder Cancer at the 2019 ASCO GU Symposium Associated PressROCKVILLE, Md., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Rexahn P
Pulmatrix Inc. (PULM) and Stemline Therapeutics Inc. (NASDAQ:STML) Comparing side by side The Yomi BlogBoth Pulmatrix Inc. (NASDAQ:PULM) and Stemline Therapeutics Inc. (NASDAQ:STML) compete on a leve
Zosano Pharma (ZSAN) & Jaguar Health (NASDAQ:JAGX) Critical Analysis Fairfield CurrentZosano Pharma (NASDAQ:ZSAN) and Jaguar Health (NASDAQ:JAGX) are both small-cap medical companies, but which is th
Spire Health Announces Launch of Research Platform for Clinical Trials WebWireSpire Health, the market leader in continuous respiration sensing and high-adherence ambulatory monitoring, is announcing
Traders Review: Surface Oncology, Inc. (NASDAQ:SURF), Antero Midstream GP LP (NYSE:AMGP) The Newburgh PressSurface Oncology, Inc. (NASDAQ:SURF) Surface Oncology, Inc. (NASDAQ:SURF), ended its previou
Article on anti-tumor activity of PV-10 against relapsed and refractory neuroblastoma published in OncoTargets and Therapy GlobeNewswireProvides preclinical proof-of-concept data on efficacy of singl